Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Zhonglian Guangzhen Pharmaceutical Group is a comprehensive healthcare enterprise based in Shenzhen, China, specializing in the research, production, and distribution of pharmaceuticals. The group is a major player in the Traditional Chinese Medicine (TCM) sector, while also maintaining a significant portfolio of chemical drugs and health supplements. Its core operations are centered around its subsidiary, Shenzhen Zhonglian Pharmaceutical, which has a history dating back to the mid-1980s. The company's product line is particularly strong in respiratory and cardiovascular therapeutic areas, featuring well-known brands in the Chinese market. With modern GMP-certified manufacturing bases, the group serves a broad clinical and retail network across mainland China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Zhonglian Guangzhen Pharmaceutical Group.